Merison

• Meniere's disease
• Meniere's syndrome
• Peripheral vertigo

Betahistine Mesilate dilates precapillary sphincters, increasing the blood flow in the inner ear. It controls the permeability of capillaries in the inner ear, thereby removing endolymphatic hydrops. It also improves cerebral circulation, increasing blood flow in the internal carotid artery. Thus, Betahistine Mesylate is clinically useful for the relief of vertigo and dizziness.

Betahistine Mesilate increases microcirculation blood flow in the inner ear, and removes endolymphatic hydrops of the inner ear. It also significantly increases the blood flow of the internal carotid artery.

Adults: 1 to 2 tablets three times per day after meals. The dose may be adjusted according to the age of patient and severity of symptoms.

• Headache
• Nausea
• Dyspepsia
• Stomach pain and bloating
• Vomiting (rare)
• Skin rash (rare)

[CONSULT YOUR DOCTOR] Information regarding the use of Betahistine Mesilate during pregnancy is not available. Use only if the expected therapeutic benefit outweighs any possible risk.

• You have been prescribed Betahistine Mesilate to relieve vertigo (dizziness), hearing problems and tinnitus (noise in the ear) associated with Meniere's disease.
• It can only decrease the number and severity of attacks but may not completely stop them.
• Taking it with food can help reduce stomach problems.
• Take it at the same time each day to maintain a steady amount of the medicine in your body.
• Inform your doctor if you have a history of stomach ulcer, asthma, or low blood pressure.
• Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
• Do not stop taking the medicine suddenly without talking to your doctor first.

Consult your doctor if symptoms of overdose occur.

Store in cool and dry place. Protect from light & moisture.